Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Coya Therapeutics | COYA | Sep 23, 2024 | 5.87 | -3.93 |
CPS Technologies | CPSH | Sep 23, 2024 | 1.40 | -2.10 |
CRA International | CRAI | Sep 23, 2024 | 167.34 | +0.19 |
Cracker Barrel Old Country Store | CBRL | Sep 23, 2024 | 40.89 | -1.64 |
Crane Company | CR | Sep 23, 2024 | 152.60 | +0.11 |
Crane NXT | CXT | Sep 23, 2024 | 58.53 | -0.80 |
Crawford & Company A | CRD-A | Sep 23, 2024 | 11.13 | +1.00 |
Crawford & Company B | CRD-B | Sep 23, 2024 | 11.46 | +0.26 |
Creative Media & Community Trust | CMCT | Sep 23, 2024 | 1.97 | -4.37 |
Creative Medical Technology | CELZ | Sep 23, 2024 | 2.99 | -4.17 |
Creative Realities | CREX | Sep 23, 2024 | 4.42 | +0.45 |
Credicorp | BAP | Sep 23, 2024 | 175.70 | -2.06 |
Credit Acceptance | CACC | Sep 23, 2024 | 454.67 | +0.24 |
Credit Enhanced Corts Trust Aon Capital A | KTN | Sep 23, 2024 | 26.69 | -0.74 |
Credit Suisse Ag | SLVO | Sep 23, 2024 | 79.19 | -0.55 |
Credit Suisse Ag | GLDI | Sep 23, 2024 | 155.20 | +0.38 |
Credit Suisse Asset Management Income Fund | CIK | Sep 23, 2024 | 3.08 | 0.00 |
Credit Suisse Gold Shares Covered Calls ETN | USOI | Sep 23, 2024 | 66.62 | -0.37 |
Credit Suisse High Yield Bond Fund | DHY | Sep 23, 2024 | 2.19 | +0.92 |
Credo Technology | CRDO | Sep 23, 2024 | 29.79 | +2.09 |
Crescent Capital BDC | CCAP | Sep 23, 2024 | 18.99 | +0.58 |
Crescent Energy | CRGY | Sep 23, 2024 | 11.43 | -0.09 |
Cresud A ADR | CRESY | Sep 23, 2024 | 9.01 | +0.78 |
Crexendo | CXDO | Sep 23, 2024 | 4.60 | -2.13 |
CRH | CRH | Sep 23, 2024 | 91.97 | -0.99 |
Cricut A | CRCT | Sep 23, 2024 | 6.65 | +2.15 |
Crinetics Pharmaceuticals | CRNX | Sep 23, 2024 | 50.42 | -5.14 |
CRISPR Therapeutics | CRSP | Sep 23, 2024 | 46.74 | -2.99 |
Criteo ADR | CRTO | Sep 23, 2024 | 42.00 | 0.00 |
Critical Metals | CRML | Sep 23, 2024 | 7.10 | +1.43 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.